Literature DB >> 1549218

Low and variable presence of valproic acid in human brain.

D D Shen1, G A Ojemann, R L Rapport, R L Dills, P N Friel, R H Levy.   

Abstract

We studied the distribution of valproic acid (VPA) between brain (gray matter) and serum in 13 patients receiving chronic VPA therapy who underwent cortical resections for intractable seizures. Valproate concentration in cerebral cortex was remarkably low compared with either total or unbound valproate concentration in serum. The respective brain-to-serum partition ratios based on total and free drug in serum were 0.111 +/- 0.051 and 0.544 +/- 0.175. In comparison with other commonly used antiepileptic drugs, valproate has the distinction of exhibiting the lowest brain-to-blood partitioning. Moreover, the brain-to-serum concentration ratio varied over a four-fold range between patients. Some of this variability was related to variation in serum protein binding, as indicated by a modest correlation between the partition ratio and serum free fraction (r = +0.687). However, the brain-to-unbound concentration ratio still showed a three-fold variation. The variability in distribution of VPA between brain and blood is probably one of the underlying factors for the lack of a clearly definable therapeutic range of serum VPA concentration in epileptic patient populations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1549218     DOI: 10.1212/wnl.42.3.582

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

1.  Volume-selective 1H MR spectroscopy for in vivo detection of valproate in patients with epilepsy.

Authors:  S Seyfert; J Bernarding; J Braun
Journal:  Neuroradiology       Date:  2003-03-27       Impact factor: 2.804

2.  Assessment of tear concentrations on therapeutic drug monitoring. II. Pharmacokinetic analysis of valproic acid in guinea pig serum, cerebrospinal fluid, and tears.

Authors:  S Sato; S Kitagawa; M Nakajima; K Shimada; A Honda; H Miyazaki
Journal:  Pharm Res       Date:  2001-04       Impact factor: 4.200

Review 3.  Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience.

Authors:  Emilio Perucca
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

4.  In vivo 1H magnetic resonance spectroscopy of rat brain after valproate administration.

Authors:  J Leib; J Braun; A Schilling; C Klingner; S Seyfert; W Vollmann; E Gedat; J Bernarding
Journal:  Neuroradiology       Date:  2004-03-25       Impact factor: 2.804

5.  Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for valproic acid and divalproex.

Authors:  Todd M Conner; Vahagn C Nikolian; Patrick E Georgoff; Manjunath P Pai; Hasan B Alam; Duxin Sun; Ronald C Reed; Tao Zhang
Journal:  Eur J Pharm Sci       Date:  2017-10-10       Impact factor: 4.384

6.  Anti-seizure therapy with a long-term, implanted intra-cerebroventricular delivery system for drug-resistant epilepsy: A first-in-man study.

Authors:  Mark Cook; Michael Murphy; Kristian Bulluss; Wendyl D'Souza; Chris Plummer; Emma Priest; Catherine Williams; Ashwini Sharan; Robert Fisher; Sharon Pincus; Eric Distad; Tom Anchordoquy; Dan Abrams
Journal:  EClinicalMedicine       Date:  2020-05-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.